These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 31370775)

  • 1. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer.
    Chattopadhyay I; Verma M; Panda M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819867354. PubMed ID: 31370775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis.
    Li R; Xiao L; Gong T; Liu J; Li Y; Zhou X; Li Y; Zheng X
    Mol Oral Microbiol; 2023 Feb; 38(1):9-22. PubMed ID: 36420924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. About a Possible Impact of Endodontic Infections by
    Ciani L; Libonati A; Dri M; Pomella S; Campanella V; Barillari G
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
    Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
    Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum and oral cancer: a critical review.
    McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
    BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oral microbiome on oral cancers, a review.
    Gholizadeh P; Eslami H; Yousefi M; Asgharzadeh M; Aghazadeh M; Kafil HS
    Biomed Pharmacother; 2016 Dec; 84():552-558. PubMed ID: 27693964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral microbial dysbiosis and its performance in predicting oral cancer.
    Su SC; Chang LC; Huang HD; Peng CY; Chuang CY; Chen YT; Lu MY; Chiu YW; Chen PY; Yang SF
    Carcinogenesis; 2021 Feb; 42(1):127-135. PubMed ID: 32621740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.
    Doocey CM; Finn K; Murphy C; Guinane CM
    BMC Microbiol; 2022 Feb; 22(1):53. PubMed ID: 35151278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma.
    Lamont RJ; Fitzsimonds ZR; Wang H; Gao S
    Periodontol 2000; 2022 Jun; 89(1):154-165. PubMed ID: 35244980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review.
    Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM
    J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
    Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
    Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaerobic bacterial communities associated with oral carcinoma: Intratumoral, surface-biofilm and salivary microbiota.
    Minarovits J
    Anaerobe; 2021 Apr; 68():102300. PubMed ID: 33246097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen,
    Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö
    Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491
    [No Abstract]   [Full Text] [Related]  

  • 14. Betel nut chewing, oral premalignant lesions, and the oral microbiome.
    Hernandez BY; Zhu X; Goodman MT; Gatewood R; Mendiola P; Quinata K; Paulino YC
    PLoS One; 2017; 12(2):e0172196. PubMed ID: 28225785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who is who in oral cancer?
    Zhang WL; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
    Exp Cell Res; 2019 Nov; 384(2):111634. PubMed ID: 31541617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis.
    Pignatelli P; Romei FM; Bondi D; Giuliani M; Piattelli A; Curia MC
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the oral microbiota in cancer evolution and progression.
    Sun J; Tang Q; Yu S; Xie M; Xie Y; Chen G; Chen L
    Cancer Med; 2020 Sep; 9(17):6306-6321. PubMed ID: 32638533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum Metabolically Integrates Commensals and Pathogens in Oral Biofilms.
    Sakanaka A; Kuboniwa M; Shimma S; Alghamdi SA; Mayumi S; Lamont RJ; Fukusaki E; Amano A
    mSystems; 2022 Aug; 7(4):e0017022. PubMed ID: 35852319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Pathways Triggered by
    de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
    Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.